Vivani Medical, (NASDAQ:VANI) a company focused on implantable devices in the healthcare technology sector, is listed on the ...

VANI is set to spin off Cortigent, aiming to sharpen its focus on drug implants and unlock long-term value for both entities.

Vivani Medical is developing GLP-1 subdermal implants that aim to provide a consistent therapeutic dose for six months, and ...

Requesting Health Care Proxy Access for Adolescent Patients (12-17 years) Parents and legal guardians (collectively, “Legal Guardians”) of minor patients (age 0-17) of Hospital for Special Surgery, ...

Vivani Medical (Nasdaq:VANI) announced that it filed a Form 10 registration statement with the SEC to spin off its ...

Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for ...

Detailed price information for Clearside Biomedi (CLSD-Q) from The Globe and Mail including charting and trades.

ByInvesting.com • Feb 28, 2024 Vivani Climbs 160% Following Positive NPM-115 Preclinical Weight Loss Data and Discloses NPM-139 Vivani (VANI) Climbs 160% Following Positive NPM-115 Preclinical ...

Detailed price information for Neurosense Therapeutics Ltd (NRSN-Q) from The Globe and Mail including charting and trades.

Vivani Medical, Inc. (VANI): Develops visual prosthetics, giving the blind a shot at sight. It’s not sci-fi; it’s FDA territory. The minute Apple or Meta says, “We're integrating brain ...

A major health care provider is making cuts, and it likely won’t be the last. Valley Medical Center is closing five clinics, including an urgent care center in Renton. It’s consolidating two ...

Discovery warns that South Africans without medical aid will face significant penalties for joining later in life. This is the message from CEO and founder, Adrian Gore, at Discovery’s interim ...